The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).

U.S. Rep. Bob Latta, R-Bowing Green; Rep. Diana DeGette, D-Colorado; Rep. Dan Crenshaw, R-Texas; and Rep. Debbie Dingell, ...

Despite the setback with the Oncologic Drugs Advisory Committee vote, GSK emphasizes the unmet need in multiple myeloma and ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today provides an update on its commercial and operational ...

Below, check out the roundup of California Healthline's coverage. For today's national health news, read KFF Health News' Morning Briefing.

Low energy, poor physical performance, and weak muscles make you feel old and tired. The good news is that there are supplements with natural ingredients that m ...

FY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses ...

Antimicrobial resistance (AMR) is a critical global health threat, with ESKAPE pathogens — Enterococcus faecium, ...

GUANGZHOU, China I July 16, 2025 I Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Nigerian importers may experience a reduction in duty pay as the Nigeria Customs Service plans to scrap the one per cent Comprehensive Import Supervision Scheme and seven per cent Cost of Collection ...

The integration of microfluidics and nanotechnology has revolutionized the landscape of cancer research, offering ...

The long-awaited GOP proposal moves Harrisburg’s marijuana talks forward, but the issue still divides the Pa. Senate.